The FDA has cleared PrecivityAD2, a single blood test designed to help health care professionals rule in or rule out an ...
The ability of the Geneva homologous recombination deficiency (HRD) test to predict progression-free survival (PFS) in patients with high-grade ovarian cancer treated with poly (ADP-ribose) polymerase ...
November 19, 2007 (New Orleans) — The Brückner test (BT) was suggested as a screening option for children who could not receive the usual methods of screening in a study presented here at the American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results